Centre for Research on Inner City Health, Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Ontario, Canada.
Diabetes Care. 2012 May;35(5):1038-46. doi: 10.2337/dc11-1402. Epub 2012 Mar 28.
We assessed the impact of a diabetes incentive code introduced for primary care physicians in Ontario, Canada, in 2002 on quality of diabetes care at the population and patient level.
We analyzed administrative data for 757,928 Ontarians with diabetes to examine the use of the code and receipt of three evidence-based monitoring tests from 2006 to 2008. We assessed testing rates over time and before and after billing of the incentive code.
One-quarter of Ontarians with diabetes had an incentive code billed by their physician. The proportion receiving the optimal number of all three monitoring tests (HbA(1c), cholesterol, and eye tests) rose gradually from 16% in 2000 to 27% in 2008. Individuals who were younger, lived in rural areas, were not enrolled in a primary care model, or had a mental illness were less likely to receive all three recommended tests. Patients with higher numbers of incentive code billings in 2006-2008 were more likely to receive recommended testing but also were more likely to have received the highest level of recommended testing prior to introduction of the incentive code. Following the same patients over time, improvement in recommended testing was no greater after billing of the first incentive code than before.
The diabetes incentive code led to minimal improvement in quality of diabetes care at the population and patient level. Our findings suggest that physicians who provide the highest quality care prior to incentives may be those most likely to claim incentive payments.
我们评估了 2002 年在加拿大安大略省为初级保健医生引入的糖尿病激励代码对人群和患者层面的糖尿病护理质量的影响。
我们分析了 757928 名安大略省糖尿病患者的行政数据,以检查 2006 年至 2008 年该代码的使用情况和三种基于证据的监测测试的结果。我们评估了随时间的测试率以及在计费激励代码之前和之后。
四分之一的糖尿病患者的医生开具了激励代码。接受所有三种监测测试(HbA1c、胆固醇和眼部检查)最佳数量的比例从 2000 年的 16%逐渐上升到 2008 年的 27%。年龄较小、居住在农村地区、未参加初级保健模式或患有精神疾病的个体接受所有三种推荐测试的可能性较低。在 2006-2008 年,激励代码计费数量较高的患者更有可能接受推荐的测试,但也更有可能在引入激励代码之前接受最高水平的推荐测试。随着时间的推移,对同一患者进行随访,在开具第一张激励代码后,推荐测试的改善并不比之前更大。
糖尿病激励代码仅导致人群和患者层面的糖尿病护理质量略有改善。我们的研究结果表明,在激励措施之前提供最高质量护理的医生可能是最有可能获得激励性付款的医生。